Cardiac RNase Z edited via CRISPR-Cas9 drives heart hypertrophy in Drosophila

Cardiomyopathy (CM) is a group of diseases distinguished by morphological and functional abnormalities in the myocardium. It is etiologically heterogeneous and may develop via cell autonomous and/or non-autonomous mechanisms. One of the most severe forms of CM has been linked to the deficiency of th...

Full description

Bibliographic Details
Main Authors: Ekaterina Migunova, Saathvika Rajamani, Stefania Bonanni, Fei Wang, Chao Zhou, Edward B. Dubrovsky
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212119/?tool=EBI
_version_ 1827940224390397952
author Ekaterina Migunova
Saathvika Rajamani
Stefania Bonanni
Fei Wang
Chao Zhou
Edward B. Dubrovsky
author_facet Ekaterina Migunova
Saathvika Rajamani
Stefania Bonanni
Fei Wang
Chao Zhou
Edward B. Dubrovsky
author_sort Ekaterina Migunova
collection DOAJ
description Cardiomyopathy (CM) is a group of diseases distinguished by morphological and functional abnormalities in the myocardium. It is etiologically heterogeneous and may develop via cell autonomous and/or non-autonomous mechanisms. One of the most severe forms of CM has been linked to the deficiency of the ubiquitously expressed RNase Z endoribonuclease. RNase Z cleaves off the 3’-trailer of both nuclear and mitochondrial primary tRNA (pre-tRNA) transcripts. Cells mutant for RNase Z accumulate unprocessed pre-tRNA molecules. Patients carrying RNase Z variants with reduced enzymatic activity display a plethora of symptoms including muscular hypotonia, microcephaly and severe heart hypertrophy; still, they die primarily due to acute heart decompensation. Determining whether the underlying mechanism of heart malfunction is cell autonomous or not will provide an opportunity to develop novel strategies of more efficient treatments for these patients. In this study, we used CRISPR-TRiM technology to create Drosophila models that carry cardiomyopathy-linked alleles of RNase Z only in the cardiomyocytes. We found that this modification is sufficient for flies to develop heart hypertrophy and systolic dysfunction. These observations support the idea that the RNase Z linked CM is driven by cell autonomous mechanisms.
first_indexed 2024-03-13T09:06:03Z
format Article
id doaj.art-95263ed638e748ac813b900bdd3d5400
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-03-13T09:06:03Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-95263ed638e748ac813b900bdd3d54002023-05-28T05:31:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01185Cardiac RNase Z edited via CRISPR-Cas9 drives heart hypertrophy in DrosophilaEkaterina MigunovaSaathvika RajamaniStefania BonanniFei WangChao ZhouEdward B. DubrovskyCardiomyopathy (CM) is a group of diseases distinguished by morphological and functional abnormalities in the myocardium. It is etiologically heterogeneous and may develop via cell autonomous and/or non-autonomous mechanisms. One of the most severe forms of CM has been linked to the deficiency of the ubiquitously expressed RNase Z endoribonuclease. RNase Z cleaves off the 3’-trailer of both nuclear and mitochondrial primary tRNA (pre-tRNA) transcripts. Cells mutant for RNase Z accumulate unprocessed pre-tRNA molecules. Patients carrying RNase Z variants with reduced enzymatic activity display a plethora of symptoms including muscular hypotonia, microcephaly and severe heart hypertrophy; still, they die primarily due to acute heart decompensation. Determining whether the underlying mechanism of heart malfunction is cell autonomous or not will provide an opportunity to develop novel strategies of more efficient treatments for these patients. In this study, we used CRISPR-TRiM technology to create Drosophila models that carry cardiomyopathy-linked alleles of RNase Z only in the cardiomyocytes. We found that this modification is sufficient for flies to develop heart hypertrophy and systolic dysfunction. These observations support the idea that the RNase Z linked CM is driven by cell autonomous mechanisms.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212119/?tool=EBI
spellingShingle Ekaterina Migunova
Saathvika Rajamani
Stefania Bonanni
Fei Wang
Chao Zhou
Edward B. Dubrovsky
Cardiac RNase Z edited via CRISPR-Cas9 drives heart hypertrophy in Drosophila
PLoS ONE
title Cardiac RNase Z edited via CRISPR-Cas9 drives heart hypertrophy in Drosophila
title_full Cardiac RNase Z edited via CRISPR-Cas9 drives heart hypertrophy in Drosophila
title_fullStr Cardiac RNase Z edited via CRISPR-Cas9 drives heart hypertrophy in Drosophila
title_full_unstemmed Cardiac RNase Z edited via CRISPR-Cas9 drives heart hypertrophy in Drosophila
title_short Cardiac RNase Z edited via CRISPR-Cas9 drives heart hypertrophy in Drosophila
title_sort cardiac rnase z edited via crispr cas9 drives heart hypertrophy in drosophila
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212119/?tool=EBI
work_keys_str_mv AT ekaterinamigunova cardiacrnasezeditedviacrisprcas9driveshearthypertrophyindrosophila
AT saathvikarajamani cardiacrnasezeditedviacrisprcas9driveshearthypertrophyindrosophila
AT stefaniabonanni cardiacrnasezeditedviacrisprcas9driveshearthypertrophyindrosophila
AT feiwang cardiacrnasezeditedviacrisprcas9driveshearthypertrophyindrosophila
AT chaozhou cardiacrnasezeditedviacrisprcas9driveshearthypertrophyindrosophila
AT edwardbdubrovsky cardiacrnasezeditedviacrisprcas9driveshearthypertrophyindrosophila